97 related articles for article (PubMed ID: 19879259)
1. B cells from glatiramer acetate-treated mice suppress experimental autoimmune encephalomyelitis.
Kala M; Rhodes SN; Piao WH; Shi FD; Campagnolo DI; Vollmer TL
Exp Neurol; 2010 Jan; 221(1):136-45. PubMed ID: 19879259
[TBL] [Abstract][Full Text] [Related]
2. Regulatory B cells (B10 cells) and regulatory T cells have independent roles in controlling experimental autoimmune encephalomyelitis initiation and late-phase immunopathogenesis.
Matsushita T; Horikawa M; Iwata Y; Tedder TF
J Immunol; 2010 Aug; 185(4):2240-52. PubMed ID: 20624940
[TBL] [Abstract][Full Text] [Related]
3. The immunomodulator glatiramer acetate augments the expression of neurotrophic factors in brains of experimental autoimmune encephalomyelitis mice.
Aharoni R; Eilam R; Domev H; Labunskay G; Sela M; Arnon R
Proc Natl Acad Sci U S A; 2005 Dec; 102(52):19045-50. PubMed ID: 16365293
[TBL] [Abstract][Full Text] [Related]
4. Restoration of axon conduction and motor deficits by therapeutic treatment with glatiramer acetate.
Moore S; Khalaj AJ; Patel R; Yoon J; Ichwan D; Hayardeny L; Tiwari-Woodruff SK
J Neurosci Res; 2014 Dec; 92(12):1621-36. PubMed ID: 24989965
[TBL] [Abstract][Full Text] [Related]
5. IFN-β treatment requires B cells for efficacy in neuroautoimmunity.
Schubert RD; Hu Y; Kumar G; Szeto S; Abraham P; Winderl J; Guthridge JM; Pardo G; Dunn J; Steinman L; Axtell RC
J Immunol; 2015 Mar; 194(5):2110-6. PubMed ID: 25646307
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of action of glatiramer acetate in multiple sclerosis and its potential for the development of new applications.
Arnon R; Aharoni R
Proc Natl Acad Sci U S A; 2004 Oct; 101 Suppl 2(Suppl 2):14593-8. PubMed ID: 15371592
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus-immortalized B lymphocytes exacerbate experimental autoimmune encephalomyelitis in xenograft mice.
Polepole P; Bartenslager A; Liu Y; Petro TM; Fernando S; Zhang L
J Med Virol; 2021 Jun; 93(6):3813-3823. PubMed ID: 32543727
[TBL] [Abstract][Full Text] [Related]
8. Oligodendrogenesis and myelinogenesis during postnatal development effect of glatiramer acetate.
From R; Eilam R; Bar-Lev DD; Levin-Zaidman S; Tsoory M; LoPresti P; Sela M; Arnon R; Aharoni R
Glia; 2014 Apr; 62(4):649-65. PubMed ID: 24481644
[TBL] [Abstract][Full Text] [Related]
9. Glatiramer acetate guards against rapid memory decline during relapsing-remitting experimental autoimmune encephalomyelitis.
LoPresti P
Neurochem Res; 2015 Mar; 40(3):473-9. PubMed ID: 25481047
[TBL] [Abstract][Full Text] [Related]
10. Novel liposomal glatiramer acetate: Preparation and immunomodulatory evaluation in murine model of multiple sclerosis.
Rahiman N; Zamani P; Arabi L; Alavizadeh SH; Nikpoor A; Mashreghi M; Badiee A; Jaafari MR
Int J Pharm; 2023 Dec; 648():123620. PubMed ID: 37981250
[TBL] [Abstract][Full Text] [Related]
11. Amyloid fibrils activate B-1a lymphocytes to ameliorate inflammatory brain disease.
Kurnellas MP; Ghosn EE; Schartner JM; Baker J; Rothbard JJ; Negrin RS; Herzenberg LA; Fathman CG; Steinman L; Rothbard JB
Proc Natl Acad Sci U S A; 2015 Dec; 112(49):15016-23. PubMed ID: 26621719
[TBL] [Abstract][Full Text] [Related]
12. Small molecule inhibitor of antigen binding and presentation by HLA-DR2b as a therapeutic strategy for the treatment of multiple sclerosis.
Ji N; Somanaboeina A; Dixit A; Kawamura K; Hayward NJ; Self C; Olson GL; Forsthuber TG
J Immunol; 2013 Nov; 191(10):5074-84. PubMed ID: 24123687
[TBL] [Abstract][Full Text] [Related]
13. Tissue plasminogen activator worsens experimental autoimmune encephalomyelitis by complementary actions on lymphoid and myeloid cell responses.
Hélie P; Camacho-Toledano C; Lesec L; Seillier C; Miralles AJ; Ortega MC; Guérit S; Lebas H; Bardou I; Vila-Del Sol V; Vivien D; Le Mauff B; Clemente D; Docagne F; Toutirais O
J Neuroinflammation; 2021 Feb; 18(1):52. PubMed ID: 33610187
[TBL] [Abstract][Full Text] [Related]
14. Protocol to assess the tolerogenic properties of adoptively transferred dendritic cells during murine experimental autoimmune encephalomyelitis.
Vogel A; Kerndl M; Schabbauer G; Sharif O
STAR Protoc; 2022 Sep; 3(3):101653. PubMed ID: 36065293
[TBL] [Abstract][Full Text] [Related]
15. Myeloperoxidase Molecular MRI Reveals Synergistic Combination Therapy in Murine Experimental Autoimmune Neuroinflammation.
Li A; Wu Y; Pulli B; Wojtkiewicz GR; Iwamoto Y; Wang C; Li JH; Ali M; Feng X; Yao Z; Chen JW
Radiology; 2019 Oct; 293(1):158-165. PubMed ID: 31478802
[TBL] [Abstract][Full Text] [Related]
16. Seeking balance: Potentiation and inhibition of multiple sclerosis autoimmune responses by IL-6 and IL-10.
Ireland SJ; Monson NL; Davis LS
Cytokine; 2015 Jun; 73(2):236-44. PubMed ID: 25794663
[TBL] [Abstract][Full Text] [Related]
17. Caerulomycin A suppresses immunity by inhibiting T cell activity.
Singla AK; Gurram RK; Chauhan A; Khatri N; Vohra RM; Jolly RS; Agrewala JN
PLoS One; 2014; 9(10):e107051. PubMed ID: 25286329
[TBL] [Abstract][Full Text] [Related]
18. The effect of glatiramer acetate therapy on functional properties of B cells from patients with relapsing-remitting multiple sclerosis.
Ireland SJ; Guzman AA; O'Brien DE; Hughes S; Greenberg B; Flores A; Graves D; Remington G; Frohman EM; Davis LS; Monson NL
JAMA Neurol; 2014 Nov; 71(11):1421-8. PubMed ID: 25264704
[TBL] [Abstract][Full Text] [Related]
19. Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation.
Mayo L; Trauger SA; Blain M; Nadeau M; Patel B; Alvarez JI; Mascanfroni ID; Yeste A; Kivisäkk P; Kallas K; Ellezam B; Bakshi R; Prat A; Antel JP; Weiner HL; Quintana FJ
Nat Med; 2014 Oct; 20(10):1147-56. PubMed ID: 25216636
[TBL] [Abstract][Full Text] [Related]
20. Glatiramer acetate protects against inflammatory synaptopathy in experimental autoimmune encephalomyelitis.
Gentile A; Rossi S; Studer V; Motta C; De Chiara V; Musella A; Sepman H; Fresegna D; Musumeci G; Grasselli G; Haji N; Weiss S; Hayardeny L; Mandolesi G; Centonze D
J Neuroimmune Pharmacol; 2013 Jun; 8(3):651-63. PubMed ID: 23370991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
